Middle East Africa and Turkey Heart Failure Drug Market Size, Status and Forecast 2019-2025

Lowest Prices Guaranteed Length Publisher Published Date SKU
from $3,900 95 Pages QYResearch Group October, 2019 QYR16057480
Lowest Prices Guaranteed
Price from $3,900
Length 95 Pages
Publisher QYResearch Group
Published Date October, 2019
SKU QYR16057480

Middle East Africa and Turkey Heart Failure Drug Market Size, Status and Forecast 2019-2025

Summary

In 2018, the Middle East Africa and Turkey Heart Failure Drug market size was 260 million US$ and it is expected to reach 573 million US$ by the end of 2025, with a CAGR of 11.3% during 2019-2025.

This report focuses on the Middle East Africa and Turkey Heart Failure Drug status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Heart Failure Drug development in Middle East Africa and Turkey.
The key players covered in this study
Novartis
Pfizer
AstraZeneca
Hikma
Teva
Cipla
Merck & Co.
Amgen
Roche
Sun Pharma
Mylan

Market segment by Type, the product can be split into
ACEI
Angiotensin II Receptor Blockers
ARNIs
Beta Blockers
Aldosterone Antagonists
Diuretics

Market segment by Ejection Fraction Function, split into
Reduced Ejection Fraction
Preserved Ejection Fraction

Market segment by Countries, this report covers
Turkey
Egypt
South Africa
Saudi Arabia
UAE


1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Middle East Africa and Turkey Heart Failure Drug Market Size Growth Rate by Type (2019-2025)
1.4.2 Angiotensin-Converting Enzyme (ACE) Inhibitors
1.4.3 Angiotensin II Receptor Blockers
1.4.4 Angiotensin-Receptor Neprilysin Inhibitors (ARNIs)
1.4.5 Aldosterone Antagonists
1.4.6 Beta Blockers
1.4.7 Diuretics
1.5 Market by Ejection Fraction Function
1.5.1 Middle East Africa and Turkey Heart Failure Drug Market Share by Ejection Fraction Function (2019-2025)
1.5.2 Reduced Ejection Fraction
1.5.3 Preserved Ejection Fraction
1.6 Study Objectives
1.7 Years Considered
2 Middle East Africa and Turkey Growth Trends
2.1 Middle East Africa and Turkey Heart Failure Drug Market Size
2.2 Heart Failure Drug Growth Trends by Country
2.2.1 Heart Failure Drug Market Size by Country (2014-2025)
2.2.2 Heart Failure Drug Market Share by Country (2014-2019)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Opportunities
3 Market Share by Key Players
3.1 Heart Failure Drug Market Size by Manufacturers
3.1.1 Middle East Africa and Turkey Heart Failure Drug Revenue by Manufacturers (2018-2019)
3.1.2 Middle East Africa and Turkey Heart Failure Drug Revenue Market Share by Manufacturers (2018-2019)
3.1.3 Middle East Africa and Turkey Heart Failure Drug Market Concentration Ratio (CR5 and HHI)
3.2 Heart Failure Drug Key Players Head office and Area Served
3.3 Key Players Heart Failure Drug Product/Solution/Service
3.4 Establishment Year of Key Heart Failure Drugs Manufacturers
3.5 Mergers & Acquisitions, Expansion Plans
3.6 Heart Failure Drug Sales Price by Products in 2018
4 Breakdown Data by Type and Ejection Fraction Function
4.1 Middle East Africa and Turkey Heart Failure Drug Market Size by Type (2014-2019)
4.2 Middle East Africa and Turkey Heart Failure Drug Market Size by Ejection Fraction Function (2014-2019)
5 Turkey
5.1 Turkey Heart Failure Drug Market (2014-2019)
5.2 Turkey Heart Failure Drug Market Size by Type
5.3 Turkey Heart Failure Drug Market Size by Ejection Fraction Function
5.4 Heart Failure Drug Key Players in Turkey
6 Egypt
6.1 Egypt Heart Failure Drug Market (2014-2019)
6.2 Egypt Heart Failure Drug Market Size by Type
6.3 Egypt Heart Failure Drug Market Size by Ejection Fraction Function
6.4 Heart Failure Drug Key Players in Egypt
7 South Africa
7.1 South Africa Heart Failure Drug Market (2014-2019)
7.2 South Africa Heart Failure Drug Market Size by Type
7.3 South Africa Heart Failure Drug Market Size by Ejection Fraction Function
7.4 Heart Failure Drug Key Players in South Africa
8 Saudi Arabia
8.1 Saudi Arabia Heart Failure Drug Market (2014-2019)
8.2 Saudi Arabia Heart Failure Drug Market Size by Type
8.3 Saudi Arabia Heart Failure Drug Market Size by Ejection Fraction Function
8.4 Heart Failure Drug Key Players in Saudi Arabia
9 UAE
9.1 UAE Heart Failure Drug Market (2014-2019)
9.2 UAE Heart Failure Drug Market Size by Type
9.3 UAE Heart Failure Drug Market Size by Ejection Fraction Function
9.2 Heart Failure Drug Key Players in UAE
10 Analysis of Heart Failure Drugs Industry Key Manufacturers
10.1 Novartis
10.1.1 Company Profile
10.1.2 Product Information
10.1.3 Revenue and Gross Margin
10.2 Pfizer
10.2.1 Company Profile
10.2.2 Product Information
10.2.3 Revenue and Gross Margin
10.3 AstraZeneca
10.3.1 Company Profile
10.3.2 Product Information
10.3.3 Revenue and Gross Margin
10.4 Hikma
10.4.1 Company Profile
10.4.2 Product Information
10.4.3 Revenue and Gross Margin
10.5 Teva
10.5.1 Company Profile
10.5.2 Product Information
10.5.3 Revenue and Gross Margin
10.6 Cipla
10.6.1 Company Profile
10.6.2 Product Information
10.6.3 Revenue and Gross Margin
10.7 Merck & Co
10.7.1 Company Profile
10.7.2 Product Information
10.7.3 Revenue and Gross Margin
10.8 Amgen
10.8.1 Company Profile
10.8.2 Product Information
10.8.3 Revenue and Gross Margin
10.9 Roche
10.9.1 Company Profile
10.9.2 Product Information
10.9.3 Revenue and Gross Margin
10.10 Sun Pharma
10.10.1 Company Profile
10.10.2 Product Information
10.10.3 Revenue and Gross Margin
10.11 Mylan
10.11.1 Company Profile
10.11.2 Product Information
10.11.3 Revenue and Gross Margin
11 Market Forecast 2019-2025
11.1 Market Size Forecast by Country
11.2 Turkey
11.3 Egypt
11.4 South Africa
11.5 Saudi Arabia
11.6 UAE
11.7 Forxiga and SGLT2 Future Penetration Analysis
11.7.1 Forxiga and SGLT2 Introduction
11.7.2 Forxiga and SGLT2 for Heart Failure Market Share Forecast 2022-2025
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Disclaimer
13.3 Author Details
List of Tables and Figures
Table Heart Failure Drug Key Market Segments
Table Key Players Heart Failure Drug Covered in This Report
Table Middle East Africa and Turkey Heart Failure Drug Market Size Growth Rate by Type (2019-2025) (M USD)
Figure Middle East Africa and Turkey Heart Failure Drug Market Share by Type in 2018
Figure Angiotensin-Converting Enzyme (ACE) Inhibitors Features
Table of Key Players of Angiotensin-Converting Enzyme (ACE) Inhibitors
Figure Angiotensin II Receptor Blockers Features
Table of Key Players of Angiotensin II Receptor Blockers
Figure Angiotensin-Receptor Neprilysin Inhibitors (ARNIs) Features
Table of Key Players of Angiotensin-Receptor Neprilysin Inhibitors (ARNIs)
Figure Aldosterone Antagonists Features
Table of Key Players of Aldosterone Antagonists
Figure Beta Blockers Features
Table of Key Players of Beta Blockers
Figure Diuretics Features
Table of Key Players of Diuretics
Table Middle East Africa and Turkey Heart Failure Drug Market Size Growth by Ejection Fraction Function (2019-2025) (M USD)
Figure Middle East Africa and Turkey Heart Failure Drug Market Share by Ejection Fraction Function in 2018
Figure Reduced Ejection Fraction Case Studies
Figure Preserved Ejection Fraction Case Studies
Figure Heart Failure Drug Report Years Considered
Figure Middle East Africa and Turkey Heart Failure Drug Market Size and Growth Rate 2014-2025 (M USD)
Table Middle East Africa and Turkey Heart Failure Drug Market Size by Country 2014-2025 (M USD)
Table Middle East Africa and Turkey Heart Failure Drug Market Size by Country 2014-2019 (M USD)
Table Middle East Africa and Turkey Heart Failure Drug Market Share by Country 2014-2019
Figure Middle East Africa and Turkey Heart Failure Drug Market Share by Country 2014-2019
Figure Middle East Africa and Turkey Heart Failure Drug Market Share by Country 2018
Table Market Top Trends
Table Market Drivers
Table Market Opportunities
Table Middle East Africa and Turkey Heart Failure Drug Revenue by Manufacturers (2018-2019) (M USD)
Table Middle East Africa and Turkey Heart Failure Drug Market Share by Manufacturers (2018-2019)
Figure Middle East Africa and Turkey Heart Failure Drug Market Share by Manufacturers in 2018
Table Middle East Africa and Turkey Heart Failure Drug Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Key Players Head office and Area Served
Table Key Players Heart Failure Drug Product/Solution/Service
Table Establishment Year of Key Heart Failure Drugs Manufacturers
Table Mergers & Acquisitions, Expansion Plans
Table Heart Failure Drug Sales Price by Products 2018
Table Middle East Africa and Turkey Heart Failure Drug Market Size by Type (2014-2019) (M USD)
Table Middle East Africa and Turkey Heart Failure Drug Market Size Share by Type (2014-2019)
Figure Middle East Africa and Turkey Heart Failure Drug Market Share by Type (2014-2019)
Table Middle East Africa and Turkey Heart Failure Drug Market Size by Ejection Fraction Function (2014-2019) (M USD)
Table Middle East Africa and Turkey Heart Failure Drug Market Size Share by Ejection Fraction Function (2014-2019)
Figure Middle East Africa and Turkey Heart Failure Drug Market Size Market Share by Ejection Fraction Function (2014-2019)
Figure Middle East Africa and Turkey Heart Failure Drug Revenue Market Share by Ejection Fraction Function in 2018
Figure Turkey Heart Failure Drug Market Size 2014-2019 (M USD)
Table Turkey Heart Failure Drug Market Size by Type (2014-2019) (M USD)
Table Turkey Heart Failure Drug Market Share by Type (2014-2019)
Table Turkey Heart Failure Drug Market Size by Ejection Fraction Function (2014-2019) (M USD)
Table Turkey Heart Failure Drug Market Share by Ejection Fraction Function (2014-2019)
Table Heart Failure Drug Key Players in Turkey
Figure Egypt Heart Failure Drug Market Size 2014-2019 (M USD)
Table Egypt Heart Failure Drug Market Size by Type (2014-2019) (M USD)
Table Egypt Heart Failure Drug Market Share by Type (2014-2019)
Table Egypt Heart Failure Drug Market Size by Ejection Fraction Function (2014-2019) (M USD)
Table Egypt Heart Failure Drug Market Share by Ejection Fraction Function (2014-2019)
Table Heart Failure Drug Key Players in Egypt
Figure South Africa Heart Failure Drug Market Size 2014-2019 (M USD)
Table South Africa Heart Failure Drug Market Size by Type (2014-2019) (M USD)
Table South Africa Heart Failure Drug Market Share by Type (2014-2019)
Table South Africa Heart Failure Drug Market Size by Ejection Fraction Function (2014-2019) (M USD)
Table South Africa Heart Failure Drug Market Share by Ejection Fraction Function (2014-2019)
Table Heart Failure Drug Key Players in South Africa
Figure Saudi Arabia Heart Failure Drug Market Size 2014-2019 (M USD)
Table Saudi Arabia Heart Failure Drug Market Size by Type (2014-2019) (M USD)
Table Saudi Arabia Heart Failure Drug Market Share by Type (2014-2019)
Table Saudi Arabia Heart Failure Drug Market Size by Ejection Fraction Function (2014-2019) (M USD)
Table Saudi Arabia Heart Failure Drug Market Share by Ejection Fraction Function (2014-2019)
Table Heart Failure Drug Key Players in Saudi Arabia
Figure UAE Heart Failure Drug Market Size 2014-2019 (M USD)
Table UAE Heart Failure Drug Market Size by Type (2014-2019) (M USD)
Table UAE Heart Failure Drug Market Share by Type (2014-2019)
Table UAE Heart Failure Drug Market Size by Ejection Fraction Function (2014-2019) (M USD)
Table UAE Heart Failure Drug Market Share by Ejection Fraction Function (2014-2019)
Table Heart Failure Drug Key Players in UAE
Table Novartis Company Profile
Figure Heart Failure Drugs Product Picture of Novartis
Table Heart Failure Drugs Revenue (M USD) and Gross Margin of Novartis 2018-2019
Table Pfizer Company Profile
Figure Heart Failure Drugs Product Picture of Pfizer
Table Heart Failure Drugs Revenue (M USD) and Gross Margin of Pfizer 2018-2019
Table AstraZeneca Company Profile
Figure Heart Failure Drugs Product Picture of AstraZeneca
Table Heart Failure Drugs Revenue (M USD) and Gross Margin of AstraZeneca 2018-2019
Table Hikma Company Profile
Table Heart Failure Drugs Revenue (M USD) and Gross Margin of Hikma 2018-2019
Table Teva Company Profile
Figure Heart Failure Drugs Product Picture of Teva
Table Heart Failure Drugs Revenue (M USD) and Gross Margin of Teva 2018-2019
Table Cipla Company Profile
Table Heart Failure Drugs Revenue (M USD) and Gross Margin of Cipla 2018-2019
Table Merck & Co Company Profile
Figure Heart Failure Drugs Product Picture of Merck & Co
Table Heart Failure Drugs Revenue (M USD) and Gross Margin of Merck & Co 2018-2019
Table Amgen Company Profile
Figure Heart Failure Drugs Product Picture of Amgen
Table Heart Failure Drugs Revenue (M USD) and Gross Margin of Amgen 2018-2019
Table Roche Company Profile
Figure Heart Failure Drugs Product Picture of Roche
Table Heart Failure Drugs Revenue (M USD) and Gross Margin of Roche 2018-2019
Table Sun Pharma Company Profile
Figure Heart Failure Drugs Product Picture of Sun Pharma
Table Heart Failure Drugs Revenue (M USD) and Gross Margin of Sun Pharma 2018-2019
Table Mylan Company Profile
Figure Heart Failure Drugs Product Picture of Mylan
Table Heart Failure Drugs Revenue (M USD) and Gross Margin of Mylan 2018-2019
Table Middle East Africa and Turkey Heart Failure Drug Market Size by Country (M USD) 2019-2025
Figure Middle East Africa and Turkey Heart Failure Drug Market Size Share by Country (2019-2025)
Figure Middle East Africa and Turkey Heart Failure Drug Market Size Share by Country in 2025
Figure Turkey Heart Failure Drug Market Size Forecast (2019-2025) (M USD)
Figure Egypt Heart Failure Drug Market Size Forecast (2019-2025) (M USD)
Figure South Africa Heart Failure Drug Market Size Forecast (2019-2025) (M USD)
Figure Saudi Arabia Heart Failure Drug Market Size Forecast (2019-2025) (M USD)
Figure UAE Heart Failure Drug Market Size Forecast (2019-2025) (M USD)
Table Global Forxiga and SGLT2 for Heart Failure Market Size Forecast 2022-2025 (M USD)
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources

$3,900
$7,800
 
Research assistance
US: 800.298.5699
Int'l: +1.240.747.3093
Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Other tasks